The Latest in Hematology Times

Current management of AML patients

September 25, 2018

FLT3 inhibitor approved for rel/ref AML in Japan

September 25, 2018

Drug approved as part of frontline therapy for HL

September 25, 2018

Product approved to treat hemophilia A in Japan

September 25, 2018

CHMP reconsiders new indication for blinatumomab

September 24, 2018

CHMP backs proposed biosimilars of pegfilgrastim

September 24, 2018

CHMP recommends factor VIII therapy for hemophilia A

September 24, 2018

CHMP supports new indication for venetoclax

September 23, 2018

CHMP recommends mogamulizumab for MF, SS

September 22, 2018

NGS can predict AML relapse after HSCT

September 21, 2018

CK and TP53 status should be assessed together, team says

September 21, 2018

Trial sponsors fail to comply with EU rules

September 21, 2018

Related Issues

Stress linked to disease markers in CLL

September 20, 2018

NICE rejects DLBCL indication for CAR T-cell therapy

September 20, 2018

OBI-3424 receives orphan designation for ALL

September 20, 2018